Canaccord Genuity Reiterates Exact Sciences (EXAS) at Buy, 'view the shares as attractive following "takeout" speculation'
Tweet Send to a Friend
Canaccord Genuity analyst Kyle Mikson reiterated a Buy rating and $85.00 price target on Exact Sciences (NASDAQ: EXAS).The analyst commented ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
